查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1618748

下一代 IVD 市場：按產品、應用和最終用戶分類 - 2025-2030 年全球預測

Next-Generation IVD Market by Product (Consumables, Instruments, Software), Application (Autoimmune Diseases, Cardiology, Diabetes), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年下一代IVD市場規模為625.2億美元，預計2024年將達656億美元，複合年成長率為5.23%，2030年將達893.9億美元。

下一代體外診斷（IVD）市場的特點是旨在準確檢測、監測和治療疾病的先進技術和技術。其範圍和定義涵蓋了廣泛的創新診斷選項，包括分子診斷、就地檢驗以及由人工智慧和資料分析支援的整合診斷工具。對早期準確診斷、個人化醫療方法和慢性病流行的需求不斷成長，推動了對此類下一代 IVD 工具的需求。其應用涵蓋臨床診斷、腫瘤學、感染疾病和基因檢測，為醫院、診斷實驗室和研究機構等最終用戶提供服務。市場成長主要受到技術進步、非侵入性診斷的興起以及全球對降低醫療成本的重視的影響。穿戴式診斷的整合以及決策對即時資料的日益依賴帶來了機會。公司可以透過投資強力的研發、擴展到新興市場以及建立策略夥伴關係關係來增強其技術力，從而進一步利用這些機會。相反，市場限制包括先進診斷設備的高成本和嚴格的監管核准流程，這可能會阻礙創新和採用。同樣具有挑戰性的是不同醫療保健系統之間的資料隱私問題和技術互通性問題。克服這些挑戰需要專注於經濟實惠且快速的診斷解決方案的創新，增強易於使用的平台，並促進簡化技術整合的合作。此外，探索用於預測診斷和個人化患者照護的人工智慧應用可以開闢新的研究途徑。公司可以透過強調市場主導的方法、了解當地醫療保健動態以及專注於應對市場複雜性的適應性經營模式來獲得見解。隨著 IVD 格局的發展，公司應該投資漸進式和突破性創新，以保持敏捷性並保持競爭優勢。

主要市場統計
基準年[2023] 625.2億美元
預測年份 [2024] 656億美元
預測年份 [2030] 893.9億美元
複合年成長率（%） 5.23%

市場動態：揭示快速發展的下一代 IVD 市場的關鍵市場洞察

供需的動態交互作用正在改變下一代 IVD 市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球老化進展與慢性病傳播
    • 更多採用下一代 IVD 測試以改善精準醫療
  • 市場限制因素
    • 需要合格的醫療保健專業人員來改善患者照護
  • 市場機會
    • 下一代體外診斷藥物技術的進步
    • IVD 產業擴大採用照護現場檢測 (POC)
  • 市場挑戰
    • 影響下一代 IVD 的嚴格法規

波特五力：引領下一代 IVD 市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解下一代IVD市場的外部影響

外部宏觀環境因素在塑造下一代 IVD 市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解下一代IVD市場的競爭態勢

對下一代 IVD 市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 供應商的下一代 IVD 市場績效評估

FPNV定位矩陣是評估下一代IVD市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃下一代 IVD 市場的成功之路

對於想要加強在全球市場的影響力的公司來說，下一代 IVD 市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的人口正在老化，慢性病的盛行率也增加。
      • 透過擴大採用下一代 IVD 測試來改善精準醫療
    • 抑制因素
      • 改善患者照護需要合適的醫療保健專業人員
    • 機會
      • 下一代 IVD 所用技術的進步
      • IVD 產業擴大採用照護現場檢測 (POC)
    • 任務
      • 影響下一代 IVD 的嚴格法規
  • 市場區隔分析
    • 產品：透過在體外診斷中使用耗材確保準確性和可重複性
    • 應用：下一代 IVD 技術的進步可解決廣泛的感染疾病和慢性疾病
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章新一代 IVD 市場：依產品

  • 消耗品
  • 裝置
  • 軟體

第7章新一代 IVD 市場：依應用分類

  • 自體免疫疾病
  • 心臟病學
  • 糖尿病
  • 感染疾病
  • 腎臟病學
  • 腫瘤學

第 8 章 下一代 IVD 市場：依最終用戶分類

  • 學術/研究機構
  • 診斷實驗室
  • 醫院/診所

第9章北美和南美下一代IVD市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區下一代IVD市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的下一代IVD市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 策略合作：Illumina 和 Devicer Diagnostics 為 IVD 創新鋪路
    • Fapon Biotech 推動 IVD 領域發展，旨在擴展下一代療法
    • 沃特世公司推出革命性 Xevo TQ 絕對 IVD 質譜儀
  • 戰略分析和建議

公司名單

  • ABL SA Group
  • Agilent Technologies Inc.
  • Archer by Integrated DNA Technologies, Inc.
  • Becton, Dickinson and Company
  • Biomerieux SA
  • BioVendor-Laboratorni medicina AS
  • Cerba Research NV
  • Curetis NV
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fapon Biotech Inc.
  • Fulgent Genetics, Inc.
  • Geneseeq Technology Inc.
  • Genomic Labs Ltd.
  • Illumina, Inc.
  • Invivoscribe, Inc.
  • NGenBio Co., Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Pillar Biosciences Inc.
  • QIAGEN GmbH
  • Sophia Genetics SA
  • Sysmex Europe SE
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Vela Diagnostics Holding Pte Ltd.
Product Code: MRR-2E76C3E47F6A

The Next-Generation IVD Market was valued at USD 62.52 billion in 2023, expected to reach USD 65.60 billion in 2024, and is projected to grow at a CAGR of 5.23%, to USD 89.39 billion by 2030.

The next-generation in vitro diagnostics (IVD) market is characterized by advanced techniques and technologies aimed at precise detection, monitoring, and treatment of diseases. The scope and definition encompass a wide range of innovative diagnostic options, such as molecular diagnostics, point-of-care tests, and integrated diagnostic tools enhanced with AI and data analytics. The necessity for these next-gen IVD tools is driven by an increasing demand for early and accurate diagnosis, personalized medicine approaches, and the escalating prevalence of chronic diseases. Their application spans clinical diagnostics, oncology, infectious diseases, and genetic testing, serving end-users like hospitals, diagnostic laboratories, and research institutes. Market growth is primarily influenced by technological advancements, the rise of non-invasive diagnostics, and the global emphasis on healthcare cost reduction. Opportunities arise from the integration of wearable diagnostics and the growing reliance on real-time data for decision-making. Companies could further leverage these opportunities by investing in robust R&D, expanding into emerging markets, and forming strategic partnerships to enhance technological capabilities. Conversely, market limitations include high costs of advanced diagnostic equipment and stringent regulatory approval processes, which could impede innovation and deployment. Challenges also consist of data privacy concerns and technological interoperability issues among varied healthcare systems. To overcome these challenges, there is a need for innovations focusing on affordable and rapid diagnostic solutions, enhancement of user-friendly platforms, and fostering collaborations that streamline technological integration. Additionally, exploring artificial intelligence applications for predictive diagnostics and personalized patient care can open new research avenues. Businesses can gain insights by emphasizing a market-driven approach, understanding regional healthcare dynamics, and focusing on adaptable business models to navigate market complexities. As the IVD landscape evolves, companies should remain agile, investing in both incremental and breakthrough innovations to maintain competitive advantage.

KEY MARKET STATISTICS
Base Year [2023] USD 62.52 billion
Estimated Year [2024] USD 65.60 billion
Forecast Year [2030] USD 89.39 billion
CAGR (%) 5.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next-Generation IVD Market

The Next-Generation IVD Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising aging population across the globe and growing prevalence of chronic diseases
    • Increasing adoption next generation IVD tests to improve precision medicine
  • Market Restraints
    • Need of appropriate healthcare professionals to improve patient care
  • Market Opportunities
    • Advancements in technology used for next generation IVD
    • Rising adoption of Point-of-care (POC) testing in IVD industry
  • Market Challenges
    • Stringent regulations impacting the next generation IVD

Porter's Five Forces: A Strategic Tool for Navigating the Next-Generation IVD Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next-Generation IVD Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next-Generation IVD Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next-Generation IVD Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next-Generation IVD Market

A detailed market share analysis in the Next-Generation IVD Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next-Generation IVD Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next-Generation IVD Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next-Generation IVD Market

A strategic analysis of the Next-Generation IVD Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation IVD Market, highlighting leading vendors and their innovative profiles. These include ABL SA Group, Agilent Technologies Inc., Archer by Integrated DNA Technologies, Inc., Becton, Dickinson and Company, Biomerieux SA, BioVendor - Laboratorni medicina A.S., Cerba Research NV, Curetis N.V., Danaher Corporation, F. Hoffmann-La Roche Ltd., Fapon Biotech Inc., Fulgent Genetics, Inc., Geneseeq Technology Inc., Genomic Labs Ltd., Illumina, Inc., Invivoscribe, Inc., NGenBio Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pillar Biosciences Inc., QIAGEN GmbH, Sophia Genetics SA, Sysmex Europe SE, Tempus Labs, Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, and Vela Diagnostics Holding Pte Ltd..

Market Segmentation & Coverage

This research report categorizes the Next-Generation IVD Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instruments, and Software.
  • Based on Application, market is studied across Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, Nephrology, and Oncology.
  • Based on End-user, market is studied across Academic & Research Institutions, Diagnostic Laboratories, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising aging population across the globe and growing prevalence of chronic diseases
      • 5.1.1.2. Increasing adoption next generation IVD tests to improve precision medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Need of appropriate healthcare professionals to improve patient care
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technology used for next generation IVD
      • 5.1.3.2. Rising adoption of Point-of-care (POC) testing in IVD industry
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations impacting the next generation IVD
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Utilization of consumables in an in-vitro diagnostics to ensure the accuracy and reproducibility
    • 5.2.2. Application: Advancement in the next-generation IVD technology to cater wide array of infectious and chronic diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Next-Generation IVD Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Software

7. Next-Generation IVD Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cardiology
  • 7.4. Diabetes
  • 7.5. Infectious Diseases
  • 7.6. Nephrology
  • 7.7. Oncology

8. Next-Generation IVD Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals & Clinics

9. Americas Next-Generation IVD Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Next-Generation IVD Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Next-Generation IVD Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Strategic Collaboration: Illumina and Devyser Diagnostics Forge Path in IVD Innovation
    • 12.3.2. Fapon Biotech Advances IVD Landscape and Targets Next-Generation Therapeutics Expansion
    • 12.3.3. Waters Corporation Introduces Revolutionary Xevo TQ Absolute IVD Mass Spectrometer
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABL SA Group
  • 2. Agilent Technologies Inc.
  • 3. Archer by Integrated DNA Technologies, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Biomerieux SA
  • 6. BioVendor - Laboratorni medicina A.S.
  • 7. Cerba Research NV
  • 8. Curetis N.V.
  • 9. Danaher Corporation
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Fapon Biotech Inc.
  • 12. Fulgent Genetics, Inc.
  • 13. Geneseeq Technology Inc.
  • 14. Genomic Labs Ltd.
  • 15. Illumina, Inc.
  • 16. Invivoscribe, Inc.
  • 17. NGenBio Co., Ltd.
  • 18. Otsuka Pharmaceutical Co., Ltd.
  • 19. Pillar Biosciences Inc.
  • 20. QIAGEN GmbH
  • 21. Sophia Genetics SA
  • 22. Sysmex Europe SE
  • 23. Tempus Labs, Inc.
  • 24. Thermo Fisher Scientific Inc.
  • 25. Trivitron Healthcare
  • 26. Vela Diagnostics Holding Pte Ltd.

LIST OF FIGURES

  • FIGURE 1. NEXT-GENERATION IVD MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT-GENERATION IVD MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEXT-GENERATION IVD MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEXT-GENERATION IVD MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEXT-GENERATION IVD MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT-GENERATION IVD MARKET DYNAMICS
  • TABLE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NEXT-GENERATION IVD MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. NEXT-GENERATION IVD MARKET, FPNV POSITIONING MATRIX, 2023